Home › Funds › ADAR1 Capital Management, LLC › ENTA
ADAR1 Capital Management, LLC position in ENTA
ENANTA PHARMACEUTICALS INC COM · Health Care
ADAR1 Capital Management, LLC reported holding 1,344,510 shares of ENTA (ENANTA PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$19.6M, representing 1.09% of its reported portfolio and ranking #23 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ENTA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's ENTA position evolved
ADAR1 Capital Management, LLC first disclosed a stake in ENTA in Q4 2025 at 41,357 shares (US$652K). The position peaked in Q2 2026 at 1,344,510 shares, worth US$19.6M. Across 3 filings, ADAR1 Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,344,510 shares valued at US$19.6M — an increase of 1,293,153 shares quarter over quarter.. Notable position changes include a 2518% increase in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 41.36K | $652.20K | New |
| Q1 2026 | 51.36K | $648.64K | Add |
| Q2 2026 | 1.34M | $19.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENTA and 13F data
ENTA (ENANTA PHARMACEUTICALS INC COM) is a Health Care company. 28 other funds we track also report a position in ENTA — the largest reported positions include Krensavage Asset Management, LLC (US$41.8M), Farallon Capital Management (US$35.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTA
- Krensavage Asset Management, LLC 2.87M sh · $41.79M · Q2 2026
- Farallon Capital Management 2.42M sh · $35.26M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.42M sh · $35.26M · Q2 2026
- Spruce Street Capital LP 1.09M sh · $15.87M · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held ENTA?
ADAR1 Capital Management, LLC has disclosed ENTA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ADAR1 Capital Management, LLC's current position in ENTA?
As of Q2 2026, ADAR1 Capital Management, LLC holds 1.34M shares of ENTA (ENANTA PHARMACEUTICALS INC COM), valued at $19.60M, representing 1.09% of its reported portfolio and ranking #23.
Has ADAR1 Capital Management, LLC been buying or selling ENTA?
In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ENTA. The position peaked in Q2 2026 at 1.34M shares.
Which other funds hold ENTA?
Other major institutional holders of ENTA include Krensavage Asset Management, LLC, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.